Skip to content

Drug interactions

Efavirenz + Vinblastine

Severity: Moderate

Efavirenz and Vinblastine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Efavirenz may reduce vinblastine exposure by inducing its metabolism, potentially lessening antineoplastic effect. The magnitude is uncertain and is likely modest.

What this interaction means in plain words

Efavirenz and Vinblastine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Efavirenz belongs to Anti Virals; Vinblastine belongs to Oncology.

Evidence level: Low

Why it happens

Efavirenz induces CYP3A4, which is the main metabolic pathway of vinblastine.

What to do

Monitor tumor response and toxicity closely. Where an alternative antiretroviral without CYP3A4 induction is feasible, consider it during chemotherapy.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Efavirenz and Vinblastine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Efavirenz with Vinblastine?

MediHelp rates the interaction as moderate. Efavirenz and Vinblastine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Efavirenz may reduce vinblastine exposure by inducing its metabolism, potentially lessening antineoplastic effect. The magnitude is uncertain and is likely modest.

How serious is the interaction between Efavirenz and Vinblastine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor tumor response and toxicity closely. Where an alternative antiretroviral without CYP3A4 induction is feasible, consider it during chemotherapy.

What other medicines interact with Efavirenz?

MediHelp also lists interactions of Efavirenz with, for example, Cobimetinib, Dienogest / estradiol valerate, Dihydroergotamine intranasal. The full list is on the Efavirenz page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in